Drug Database · Clinicians

Aspirin + Clopidogrel

Also known as: acetylsalicylic acid (international nonproprietary name, for aspirin)

Brands (10) Clopel-A, Clopirin 100, Clopirin 75…Show all

Antithrombotic agent (platelet aggregation inhibitor) PH FDA category
Fixed-dose combination.

Contraindicated if CrCl <30Rx · Prescription drug10 PH products Kidney dosing reviewed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: Uses for the temporary relief of minor aches and pains or as recommended by your doctor. US FDA label

  • Use: Acute coronary syndrome – For patients with non–ST-segment elevation ACS (unstable angina [UA]/non–ST-elevation myocardial infarction [NSTEMI]), Plavix has been shown to reduce the rate of myocardial infarction (MI) and… US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Contraindications

  • Severe kidney impairment (CrCl <30 mL/min)
  • Severe hepatic impairment
  • Active pathological bleeding
  • NSAID or aspirin hypersensitivity (asthma, rhinitis, nasal polyps)
  • Mastocytosis
  • Third trimester of pregnancy
  • Hypersensitivity
renalcarematters.com, reviewed

Dosing: Adult

  • Acute coronary syndrome or ST-elevation myocardial infarction in patients already taking both drugs: One tablet once daily (clopidogrel 75 mg/aspirin 75 or 100 mg); duration per indication (up to 12 months after NSTE-ACS or PCI)
renalcarematters.com, reviewed

Dosing: Altered kidney function

The fixed combination of clopidogrel 75 mg with aspirin 75 or 100 mg is contraindicated in Europe in severe kidney impairment (creatinine clearance [CrCl] below 30 mL/min) because of the aspirin component, and experience in mild to moderate impairment is limited. Clopidogrel's antiplatelet effect is about 25% lower at CrCl 5–15 mL/min. It has no US FDA label.

Kidney function measure: European summary of product characteristics (SmPC) uses creatinine clearance (CrCl, mL/min).

Show full dosing details
CrCl ≥60 mL/min
Usual: one tablet once daily (clopidogrel 75 mg with aspirin 75 or 100 mg) (SmPC).
CrCl 30–59 mL/min
Mild to moderate impairment: limited experience; use with caution and watch for bleeding (SmPC).
CrCl 15–29 mL/min
Contraindicated: severe kidney impairment (CrCl <30 mL/min), because of the aspirin component (SmPC). Give clopidogrel and low-dose aspirin as separate tablets if dual therapy is needed, with specialist input.
CrCl <15 mL/min (not on dialysis)
Contraindicated: severe kidney impairment (CrCl <30 mL/min), because of the aspirin component (SmPC). Give clopidogrel and low-dose aspirin as separate tablets if dual therapy is needed, with specialist input.
Hemodialysis (intermittent)
Contraindicated as the fixed combination (severe kidney impairment). Use separate tablets if dual antiplatelet therapy is indicated; specialist input.
Peritoneal dialysis
Contraindicated as the fixed combination; use separate tablets if indicated.
CRRT
Contraindicated as the fixed combination; use separate clopidogrel and low-dose aspirin tablets if dual antiplatelet therapy is indicated.
  • Dialyzable? Not stated.
  • Monitoring Bleeding (especially the first month), platelet count (thrombocytopenia, thrombotic thrombocytopenic purpura), kidney function (acute kidney injury reported with pre-existing dysfunction). Stop 7 days before surgery if antiplatelet therapy must be interrupted (SmPC 4.4). If gastroprotection is needed, use pantoprazole rather than omeprazole or esomeprazole (SmPC 4.5).
Children (kidney dosing)
eGFR ≥60
Not established in children; kidney dosing not applicable.
eGFR 30–59
Not established in children; kidney dosing not applicable.
eGFR 15–29
Not established in children; kidney dosing not applicable.
eGFR <15 (not on dialysis)
Not established in children; kidney dosing not applicable.
Hemodialysis (intermittent)
Not established in children; kidney dosing not applicable.
Peritoneal dialysis
Not established in children; kidney dosing not applicable.
CRRT
Not established in children; kidney dosing not applicable.

Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.

renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.

Source: EMA product information. This generic has no US FDA label.

Dosing: Pediatric

Approved ages
Not recommended under 18 years (SmPC).
Usual dose
Not established.

Kidney dosing in children: see Dosing: Altered kidney function.

renalcarematters.com, reviewed

Dosage forms

Philippines

  • Capsule: 75 mg/75 mg
  • Film-coated tablet: 75 mg + 100 mg, 75 mg + 75 mg, 75 mg/100 mg, 75 mg/75 mg
  • Tablet: 75 mg/75 mg

Registered products in the Philippines

10 products registered with the Food and Drug Administration (FDA) Philippines list Aspirin + Clopidogrel as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products10
Philippine FDA-registered products for Aspirin + Clopidogrel
Package insert
Clopel-AClopidogrel (as bisulfate) + Aspirin
75 mg/75 mg CapsuleAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
Rx
Fredun Pharmaceutical LimitedIndia
AMB HK Enterprises, Inc.
DRP-11933
May 26, 2032
Clopirin 100Clopidogrel + Aspirin
75mg + 100mg Film-Coated TabletAlu-Alu Blister Pack x 10’s (Box of 30’s, 60’s and 100’s)
Rx
Unicure (India) Ltd.India
Despina Pharma Inc.
DRP-18940
Oct 5, 2031
Clopirin 75Clopidogrel + Aspirin
75mg + 75mg Film-Coated TabletAlu-Alu Blister Pack x 10’s (Box of 30’s, 60’s and 100’s)
Rx
Unicure (India) Ltd.India
Despina Pharma Inc.
DRP-18939
Oct 5, 2031
ClotisprinClopidogrel (as bisulfate) + Aspirin
75 mg/75 mg Capsule (containing Clopidogrel immediate-release pellets and Aspirin enteric-coated pellets)Alu/Alu Blister Pack x 10's Box of 100's
Rx
Pell Tech Health Care Private Ltd.India
Macropharma CorporationImporter: Ambica International Corporation
DRP-10573
Aug 26, 2029
CoplavixClopidogrel (as bisulfate) + Aspirin
75 mg/ 100 mg Film Coated TabletAlu/Alu Blister Pack of 10's Box of 30's
Rx
Sanofi Winthrop IndustrieFrance
Importer: Sanofi-Aventis Philippines, Inc.
DR-XY41364
Mar 11, 2030
Deplatt AClopidogrel (as bisulfate) + Aspirin
75 mg/75 mg Capsule (containing Clopidogrel immediate-release pellets and Aspirin enteric-coated pellets)Alu/Alu Blister Pack x 10's (Box of 100's)
Rx
Pell Tech Health Care Private Ltd.India
Torrent Pharma Philippines, Inc.Importer: Ambica International Corporation
DRP-10573-01
Aug 26, 2029
Ecosprin PlusClopidogrel (as bisulfate) + Aspirin
75 mg/75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
The ACME Laboratories LimitedBangladesh
Bell-Kenz Pharma Inc.Importer: Euro Generics International Phils., Inc.
DR-XY44448
Apr 10, 2030
Norplat-SClopidogrel + Aspirin
75 mg /75 mg TabletAlu/Alu Blister Pack x 10’s (Box of 10's)
Rx
Getz Pharma Pvt. Ltd.Pakistan
Importer: Getz Pharma (Phils.), Inc.
DR-XY39071
Feb 9, 2027
Plat-Low EAClopidogrel (as bisulfate) + Aspirin
75 mg/75 mg CapsuleAlu/Alu Blister Pack x 10’s (Box of 100's)
Rx
Fredun Pharmaceuticals LimitedIndia
CCL Pharmaceuticals (Philippines), Inc.Importer: AMB HK Enterprises Inc.
DRP-11933-02
May 26, 2027
ValdorinClopidogrel (as bisulfate) + Aspirin
75 mg/75 mg CapsuleAlu/Alu Blister Pack x 10’s (Box of 100’s)
Rx
Fredun Pharmaceuticals LimitedIndia
Corbridge Group Phils., Inc.Importer: AMB Hk Enterprises Inc.
DRP-11933-01
May 26, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Drug interactions

Drug or classSeverityEffectWhat to do
Omeprazole, esomeprazoleAvoidLess clopidogrel active metabolite.Avoid; pantoprazole has a smaller effect.
Oral anticoagulantsAvoidMore bleeding.Not recommended.
NSAIDs including COX-2 inhibitors, SSRIs, heparin, thrombolytics, GP IIb/IIIa antagonistsAdjust or monitorMore bleeding.Use with caution.
Strong CYP2C19 inducers (rifampicin); ritonavir- or cobicistat-boosted regimensAvoidAltered clopidogrel activation.Avoid.
Methotrexate above 20 mg/weekAdjust or monitorAspirin lowers methotrexate clearance.Use with caution.
CYP2C8 substrates (repaglinide, paclitaxel); rosuvastatinMinorHigher exposure (rosuvastatin about 1.4-fold).Use with caution.

Severity scale (renalcarematters.com): Avoid: do not combine; Adjust or monitor: change the dose or monitor closely; Minor: usually no action.

renalcarematters.com, reviewed

Adverse reactions

Common

  • Bleeding, bruising
  • Dyspepsia, diarrhea, abdominal pain

Serious

  • Gastrointestinal and intracranial bleeding
  • Thrombotic thrombocytopenic purpura, aplastic anemia, agranulocytosis (rare)
  • Anaphylaxis, angioedema
  • Acute kidney impairment (rare, mainly with pre-existing dysfunction)
renalcarematters.com, reviewed

Monitoring parameters

  • Bleeding (especially the first month), platelet count (thrombocytopenia, thrombotic thrombocytopenic purpura), kidney function (acute kidney injury reported with pre-existing dysfunction). Stop 7 days before surgery if antiplatelet therapy must be interrupted (SmPC 4.4). If gastroprotection is needed, use pantoprazole rather than omeprazole or esomeprazole (SmPC 4.5). Kidney
  • Bleeding signs
  • Platelets if symptoms
  • Kidney function in CKD
renalcarematters.com, reviewed

Pharmacokinetics

Key PK parameters

Half-lifeClopidogrel about 6 hours (inactive metabolite 8 hours); aspirin 0.3 to 0.4 hours; salicylic acid about 2 hours
Half-life in kidney failure (ESKD) kidneyAt CrCl 5–15, clopidogrel platelet inhibition about 25% lower; bleeding time similar
Metabolism (CYP, transporters)Clopidogrel: prodrug activated partly by CYP2C19; aspirin hydrolyzed to salicylic acid
Active metabolitesClopidogrel thiol metabolite; salicylic acid
Renal excretion kidneyClopidogrel about 50% in urine, 46% in feces (120 hours); salicylate renal excretion depends on urine pH
Dialyzability kidneyNot stated
renalcarematters.com, reviewed

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. European Medicines Agency. DuoPlavin EPAR product information (SmPC) [EMA product information; no US FDA label]. https://www.ema.europa.eu/en/documents/product-information/duoplavin-epar-product-information_en.pdf
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. European Medicines Agency. (n.d.). DuoPlavin (clopidogrel/acetylsalicylic acid): EPAR product information [Summary of product characteristics]. Sanofi Winthrop Industrie. Retrieved November 17, 2026. https://www.ema.europa.eu/en/documents/product-information/duoplavin-epar-product-information_en.pdf

renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .